SBIR/STTR Research Award
Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Gemneo Bioscience, Inc.
- Proposal award date
- 2018-09-17
- Contract end date
- 2019-02-28
- UEI
- Not reported
- Solicitation number
- PAR18-303
- Topic code
- 100
Research abstract
Project Summary Abstract
Next generation sequencing platforms have revolutionized modern approaches for understanding a wide
variety of biological processesincluding immune responses and cancerHoweverincreasing evidence shows
that the diversity of the cells involved in these processes has important implications for understanding biologic
outcomesFor instancethe diversity of T cell receptors on lymphocytes during responses to virus or cancer
can have dramatic effects on disease outcomeConverselythe diversity of cancer cells has important
implications for successful control of diseaseThereforea critical hurdle in these situations is the ability to
provide single cell analysis techniques coupled with high throughput next generation sequencingto
adequately measure the diversity of cellsUnfortunatelycurrent single cell analysis approaches are either
unfeasible for large cell populationstoo expensiveand or require specialized equipment that is not available
to most labs while bulk sequencing approaches provide no information on individual cellsTo address this
problemwe have engineered DNA origami nanostructures that are able to specifically bind and protect two
different mRNA within transfected cellsand used DNA origami specific matching barcodes upstream of
capture sequences to generate to identify in HT NGS output sequences which sequences came from the same
nanostructure and therefore from the same transfected cellIn this proposal we develop this approach for
quantitating the diversity of clonally distributed TCRand TCRT cell receptors in human T lymphocyte
populations and directly compare the throughputefficiencycost and error rates to both conventional bulksequencing and single cell sequencing approachesWe have previously developed this approach for analysis
of mouse TCR pairs from primary T cellsand expect little difficulty in adapting this modular platform to human
T cellsThis technology will be useful for downstream application to a wide variety of biologic processesby
relatively simple modifications to the DNA origami nanostructure probe sequencesincluding single cell
analysis of other diverse lymphocyte populationsincluding other T cell subsets or antibody producing B cellsas well as single cells analysis of heterogeneous tumors or diverse microbial communitiesMoreoverbecause
this approach utilizes equipment found in most modern molecular biology laboratoriesit could be easily
adopted by many researchers for these analyses Project Narrative
Gemneo Biosciences has developed a novel approach for obtaining single cell sequence information on gene
pairs while maintaining the high throughputlow costand high efficiency of bulk sequencing approachesWe
will apply this method to analysis of human TCRpairs from primary cellsand directly compare the costefficiencythroughputand error rates to conventional single cell RNA or bulk DNA analysis methodsThis will
facilitate rapid transition to market with product for analysis of TCR in a multitude of immune oncology projects
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing